As a pioneer in self-developed biomedical materials in China, Imeik has charted its innovation path since its inception. In 2012, we established the Beijing Engineering Laboratory for Biodegradable New Materials, achieving breakthroughs in R&D efficiency, system development, and market influence. Our newly constructed R&D center commenced operations in 2022, featuring dedicated platforms for medical device innovation and biotechnology research. This facility drives interdisciplinary R&D across medical devices, biologics, and cosmetics.

By strengthening core technological capabilities and brand development, we foster deep integration across industry, academia, research, and medical communities, positioning the center as a leading scientific institution with proprietary technologies, domestic leadership, and international competitiveness.